オリゴヌクレオチド合成の世界市場：市場規模・シェア・動向分析 (製品別、用途別、最終用途別、地域別)、セグメント別予測 (2025年～2030年)

オリゴヌクレオチド合成市場の成長と動向：

Grand View Research, Incの最新レポートによると、世界のオリゴヌクレオチド合成の市場規模は、2025年から2030年にかけて13.2%のCAGRを記録し、2030年までに88億3,000万米ドルに達すると予測されています。

臨床試験中のオリゴヌクレオチド治療薬の強力なパイプライン、遺伝子編集技術の進歩、バイオテクノロジー企業による研究開発費の増加は、市場成長を促進する主な要因の一部です。

オリゴヌクレオチド治療薬の参加企業は臨床試験の後期段階にあり、予測期間中に承認・商業化されると予想されます。企業はオリゴヌクレオチドベースの治療薬を開発するために投資を増やしています。2023年10月、GSK plcとアローヘッド・ファーマシューティカルズは、ジョンソン・エンド・ジョンソンのヤンセン・ファーマシューティカルズ・インク（ヤンセン）と、JNJ-3989を開発・商業化する独占的な世界的権利をGSKに譲渡する契約を締結したと発表しました。ヤンセンは当初、2018年にアローヘッドからJNJ-3989（以前はARO-HBV）を導入しました。老舗製薬企業による同様の取り組みが、予測期間中の市場成長を促進すると予想されます。

ラボについてはメディケイド＆メディケアサービスセンター（Centers for Medicaid &Medicare Services）、マーケティングについては連邦取引委員会（Federal Trade Commission）、キット＆情報についてはFDAといった政府機関は、ゲノミクス＆遺伝子検査の安全で適切かつ正確な応用の監視に関与しており、ゲノミクスの成功に重要な役割を果たしています。NIHやウェルカム・トラストなどの国際的な資金提供機関は、遺伝子研究に資金を提供しており、先進経済諸国や新興経済諸国におけるゲノム研究に拍車をかけると期待されています。

2021年5月、英国政府はゲノミクス研究とデータ駆動型イニシアチブのために4,340万米ドル（3,700万英ポンド）の資金提供を発表し、2019年9月に開始されたUK Functional Genomics InitiativeとGenome UK Implementation Planを通じて提供されました。ゲノムUK戦略は、新生児シーケンスの潜在的価値を調査するために1,990万米ドル（1,700万英ポンド）を受け取るGenomics Englandプロジェクトの助けを借りて実施されます。

オリゴヌクレオチド合成市場：分析概要

• サービス分野がオリゴヌクレオチド合成市場を独占し、2024年には31.5%の最大収益シェアを占めています。オリゴヌクレオチド分野は予測期間中CAGR 13.0%の大幅な成長が見込まれます。
• PCRプライマーは、2024年に最大の収益シェアでオリゴヌクレオチド合成業界をリードしました。シーケンシングセグメントは、予測期間中最も速いCAGRで成長すると予測されています。
• 学術研究機関は、2024年に最大の収益シェアでオリゴヌクレオチド合成市場を独占しました。製薬・バイオテクノロジー企業セグメントは、予測期間中に大きく成長すると予測されています。
• 北米のオリゴヌクレオチド合成市場は、2024年に31.9％の最大収益シェアでオリゴヌクレオチド合成産業を支配しました。アジア太平洋のオリゴヌクレオチド合成市場は、予測期間中に14.9％のCAGRで最速成長すると予測されています。

目次

第1章 分析方法・範囲

第2章 エグゼクティブサマリー

第3章 オリゴヌクレオチド合成市場：変動要因・傾向・範囲

• 市場連関の見通し
  • 親市場の見通し
  • 関連/付随市場の見通し
• 市場力学
  • 市場促進要因の分析
  • 市場抑制要因の分析
• ビジネス環境分析
  • 業界分析：ポーターのファイブフォース分析
  • PESTEL分析

第4章 オリゴヌクレオチド合成市場：製品別のビジネス分析

• 市場シェア：製品別（2024年・2030年）
• セグメントダッシュボード：製品別
• 市場規模の予測と動向分析：製品別（2018～2030年）
• オリゴヌクレオチド
• 機材/シンセサイザー
• 試薬
• サービス

第5章 オリゴヌクレオチド合成市場：用途別のビジネス分析

• 市場シェア：用途別（2024年・2030年）
• セグメントダッシュボード：用途別
• 市場規模の予測と動向分析：用途別（2018～2030年）
• PCRプライマー
• PCRアッセイ・パネル
• シーケンシング
• DNAマイクロアレイ
• 蛍光in situハイブリダイゼーション（FISH）
• アンチセンスオリゴヌクレオチド
• その他の用途

第6章 オリゴヌクレオチド合成市場：最終用途別のビジネス分析

• 市場シェア：最終用途別（2024年・2030年）
• セグメントダッシュボード：最終用途別
• 市場規模の予測と動向分析：最終用途別（2018～2030年）
• 学術研究機関
• 診断検査室
• 製薬・バイオテクノロジー企業

第7章 オリゴヌクレオチド合成市場：地域別の推定・動向分析

• 市場シェア分析：地域別（2024年・2030年）
• 市場ダッシュボード：地域別
• 市場規模の予測と動向分析（2018年～2030年）
• 北米
  • 国別（2018年～2030年）
  • 米国
  • カナダ
  • メキシコ
• 欧州
  • 国別（2018年～2030年）
  • ドイツ
  • 英国
  • フランス
  • イタリア
  • スペイン
  • デンマーク
  • スウェーデン
  • ノルウェー
• アジア太平洋
  • 国別（2018年～2030年）
  • 中国
  • インド
  • 日本
  • オーストラリア
  • 韓国
  • タイ
• ラテンアメリカ
  • 国別（2018年～2030年）
  • ブラジル
  • アルゼンチン
• 中東・アフリカ
  • 国別（2018年～2030年）
  • 南アフリカ
  • サウジアラビア
  • アラブ首長国連邦
  • クウェート

第8章 競合情勢

• 参入企業の概要
• 企業の市況分析
• 企業分類
• 戦略マッピング
• 企業プロファイル/上場企業
  • Thermo Fisher Scientific Inc.
  • Merck KGaA
  • Danaher
  • Revvity Discovery Limited
  • Agilent Technologies, Inc.
  • Bio-Synthesis, Inc.
  • Kaneka Eurogentec SA
  • LGC Biosearch Technologies
  • Biolegio
  • Twist Bioscience

List of Tables

• Table 1. List of secondary sources
• Table 2. List of abbreviations
• Table 3. Global oligonucleotide synthesis market, by region, 2018 - 2030 (USD Million)
• Table 4. Global oligonucleotide synthesis market, by product, 2018 - 2030 (USD Million)
• Table 5. Global oligonucleotide synthesis market, by application, 2018 - 2030 (USD Million)
• Table 6. Global oligonucleotide synthesis market, by end use, 2018 - 2030 (USD Million)
• Table 7. North America oligonucleotide synthesis market, by country, 2018 - 2030 (USD Million)
• Table 8. North America oligonucleotide synthesis market, by product, 2018 - 2030 (USD Million)
• Table 9. North America oligonucleotide synthesis market, by application, 2018 - 2030 (USD Million)
• Table 10. North America oligonucleotide synthesis market, by end use, 2018 - 2030 (USD Million)
• Table 11. U.S. oligonucleotide synthesis market, by product, 2018 - 2030 (USD Million)
• Table 12. U.S. oligonucleotide synthesis market, by application, 2018 - 2030 (USD Million)
• Table 13. U.S. oligonucleotide synthesis market, by end use, 2018 - 2030 (USD Million)
• Table 14. Canada oligonucleotide synthesis market, by product, 2018 - 2030 (USD Million)
• Table 15. Canada oligonucleotide synthesis market, by end use, 2018 - 2030 (USD Million)
• Table 16. Canada oligonucleotide synthesis market, by application, 2018 - 2030 (USD Million)
• Table 17. Mexico oligonucleotide synthesis market, by product, 2018 - 2030 (USD Million)
• Table 18. Mexico oligonucleotide synthesis market, by application, 2018 - 2030 (USD Million)
• Table 19. Mexico oligonucleotide synthesis market, by end use, 2018 - 2030 (USD Million)
• Table 20. Europe oligonucleotide synthesis market, by country, 2018 - 2030 (USD Million)
• Table 21. Europe oligonucleotide synthesis market, by product, 2018 - 2030 (USD Million)
• Table 22. Europe oligonucleotide synthesis market, by application, 2018 - 2030 (USD Million)
• Table 23. Europe oligonucleotide synthesis market, by end use, 2018 - 2030 (USD Million)
• Table 24. Germany oligonucleotide synthesis market, by product, 2018 - 2030 (USD Million)
• Table 25. Germany oligonucleotide synthesis market, by application, 2018 - 2030 (USD Million)
• Table 26. Germany oligonucleotide synthesis market, by end use, 2018 - 2030 (USD Million)
• Table 27. UK oligonucleotide synthesis market, by product, 2018 - 2030 (USD Million)
• Table 28. UK oligonucleotide synthesis market, by application, 2018 - 2030 (USD Million)
• Table 29. UK oligonucleotide synthesis market, by end use, 2018 - 2030 (USD Million)
• Table 30. France oligonucleotide synthesis market, by product, 2018 - 2030 (USD Million)
• Table 31. France oligonucleotide synthesis market, by application, 2018 - 2030 (USD Million)
• Table 32. France oligonucleotide synthesis market, by end use, 2018 - 2030 (USD Million)
• Table 33. Italy oligonucleotide synthesis market, by product, 2018 - 2030 (USD Million)
• Table 34. Italy oligonucleotide synthesis market, by application, 2018 - 2030 (USD Million)
• Table 35. Italy oligonucleotide synthesis market, by end use, 2018 - 2030 (USD Million)
• Table 36. Spain oligonucleotide synthesis market, by product, 2018 - 2030 (USD Million)
• Table 37. Spain oligonucleotide synthesis market, by application, 2018 - 2030 (USD Million)
• Table 38. Spain oligonucleotide synthesis market, by end use, 2018 - 2030 (USD Million)
• Table 39. Denmark oligonucleotide synthesis market, by product, 2018 - 2030 (USD Million)
• Table 40. Denmark oligonucleotide synthesis market, by application, 2018 - 2030 (USD Million)
• Table 41. Denmark oligonucleotide synthesis market, by end use, 2018 - 2030 (USD Million)
• Table 42. Sweden oligonucleotide synthesis market, by product, 2018 - 2030 (USD Million)
• Table 43. Sweden oligonucleotide synthesis market, by application, 2018 - 2030 (USD Million)
• Table 44. Sweden oligonucleotide synthesis market, by end use, 2018 - 2030 (USD Million)
• Table 45. Norway oligonucleotide synthesis market, by product, 2018 - 2030 (USD Million)
• Table 46. Norway oligonucleotide synthesis market, by application, 2018 - 2030 (USD Million)
• Table 47. Norway oligonucleotide synthesis market, by end use, 2018 - 2030 (USD Million)
• Table 48. Asia Pacific oligonucleotide synthesis market, by country, 2018 - 2030 (USD Million)
• Table 49. Asia Pacific oligonucleotide synthesis market, by product, 2018 - 2030 (USD Million)
• Table 50. Asia Pacific oligonucleotide synthesis market, by application, 2018 - 2030 (USD Million)
• Table 51. Asia Pacific oligonucleotide synthesis market, by end use, 2018 - 2030 (USD Million)
• Table 52. China oligonucleotide synthesis market, by product, 2018 - 2030 (USD Million)
• Table 53. China oligonucleotide synthesis market, by application, 2018 - 2030 (USD Million)
• Table 54. China oligonucleotide synthesis market, by end use, 2018 - 2030 (USD Million)
• Table 55. India oligonucleotide synthesis market, by product, 2018 - 2030 (USD Million)
• Table 56. India oligonucleotide synthesis market, by application, 2018 - 2030 (USD Million)
• Table 57. India oligonucleotide synthesis market, by end use, 2018 - 2030 (USD Million)
• Table 58. Japan oligonucleotide synthesis market, by product, 2018 - 2030 (USD Million)
• Table 59. Japan oligonucleotide synthesis market, by application, 2018 - 2030 (USD Million)
• Table 60. Japan oligonucleotide synthesis market, by end use, 2018 - 2030 (USD Million)
• Table 61. Australia oligonucleotide synthesis market, by product, 2018 - 2030 (USD Million)
• Table 62. Australia oligonucleotide synthesis market, by application, 2018 - 2030 (USD Million)
• Table 63. Australia oligonucleotide synthesis market, by end use, 2018 - 2030 (USD Million)
• Table 64. South Korea oligonucleotide synthesis market, by product, 2018 - 2030 (USD Million)
• Table 65. South Korea oligonucleotide synthesis market, by application, 2018 - 2030 (USD Million)
• Table 66. South Korea oligonucleotide synthesis market, by end use, 2018 - 2030 (USD Million)
• Table 67. Thailand oligonucleotide synthesis market, by product, 2018 - 2030 (USD Million)
• Table 68. Thailand oligonucleotide synthesis market, by application, 2018 - 2030 (USD Million)
• Table 69. Thailand oligonucleotide synthesis market, by end use, 2018 - 2030 (USD Million)
• Table 70. Latin America oligonucleotide synthesis market, by country, 2018 - 2030 (USD Million)
• Table 71. Latin America oligonucleotide synthesis market, by product, 2018 - 2030 (USD Million)
• Table 72. Latin America oligonucleotide synthesis market, by application, 2018 - 2030 (USD Million)
• Table 73. Latin America oligonucleotide synthesis market, by end use, 2018 - 2030 (USD Million)
• Table 74. Brazil oligonucleotide synthesis market, by product, 2018 - 2030 (USD Million)
• Table 75. Brazil oligonucleotide synthesis market, by application, 2018 - 2030 (USD Million)
• Table 76. Brazil oligonucleotide synthesis market, by end use, 2018 - 2030 (USD Million)
• Table 77. Argentina oligonucleotide synthesis market, by product, 2018 - 2030 (USD Million)
• Table 78. Argentina oligonucleotide synthesis market, by application, 2018 - 2030 (USD Million)
• Table 79. Argentina oligonucleotide synthesis market, by end use, 2018 - 2030 (USD Million)
• Table 80. Middle East & Africa oligonucleotide synthesis market, by country, 2018 - 2030 (USD Million)
• Table 81. Middle East & Africa oligonucleotide synthesis market, by product, 2018 - 2030 (USD Million)
• Table 82. Middle East & Africa oligonucleotide synthesis market, by application, 2018 - 2030 (USD Million)
• Table 83. Middle East & Africa oligonucleotide synthesis market, by end use, 2018 - 2030 (USD Million)
• Table 84. South Africa oligonucleotide synthesis market, by product, 2018 - 2030 (USD Million)
• Table 85. South Africa oligonucleotide synthesis market, by application, 2018 - 2030 (USD Million)
• Table 86. South Africa oligonucleotide synthesis market, by end use, 2018 - 2030 (USD Million)
• Table 87. Saudi Arabia oligonucleotide synthesis market, by product, 2018 - 2030 (USD Million)
• Table 88. Saudi Arabia oligonucleotide synthesis market, by application, 2018 - 2030 (USD Million)
• Table 89. Saudi Arabia oligonucleotide synthesis market, by end use, 2018 - 2030 (USD Million)
• Table 90. UAE oligonucleotide synthesis market, by product, 2018 - 2030 (USD Million)
• Table 91. UAE oligonucleotide synthesis market, by application, 2018 - 2030 (USD Million)
• Table 92. UAE oligonucleotide synthesis market, by end use, 2018 - 2030 (USD Million)
• Table 93. Kuwait oligonucleotide synthesis market, by product, 2018 - 2030 (USD Million)
• Table 94. Kuwait oligonucleotide synthesis market, by application, 2018 - 2030 (USD Million)
• Table 95. Kuwait oligonucleotide synthesis market, by end use, 2018 - 2030 (USD Million)

List of Figures

• Fig. 1 Oligonucleotide synthesis market segmentation
• Fig. 2 Market research process
• Fig. 3 Data triangulation techniques
• Fig. 4 Primary research pattern
• Fig. 5 Market research approaches
• Fig. 6 Value-chain-based sizing & forecasting
• Fig. 7 Market formulation & validation
• Fig. 8 Product outlook (USD Million)
• Fig. 9 Application outlook (USD Million)
• Fig. 10 End use Market snapshot
• Fig. 11 Competitive landscape
• Fig. 12 Oligonucleotide synthesis market dynamics
• Fig. 13 Oligonucleotide synthesis market: Porter's five forces analysis
• Fig. 14 Oligonucleotide synthesis market: Pestle analysis
• Fig. 15 Oligonucleotide synthesis market: Product segment dashboard
• Fig. 16 Oligonucleotide synthesis market: Product market share analysis, 2024 & 2030
• Fig. 17 Oligonucleotides market, 2018 - 2030 (USD Million)
• Fig. 18 Product type market, 2018 - 2030 (USD Million)
• Fig. 19 Column-based Oligos market, 2018 - 2030 (USD Million)
• Fig. 20 Array-based Oligos market, 2018 - 2030 (USD Million)
• Fig. 21 Nucleic acid type market, 2018 - 2030 (USD Million)
• Fig. 22 DNA market, 2018 - 2030 (USD Million)
• Fig. 23 RNA market, 2018 - 2030 (USD Million)
• Fig. 24 Equipment/Synthesizer market, 2018 - 2030 (USD Million)
• Fig. 25 Reagents market, 2018 - 2030 (USD Million)
• Fig. 26 Services market, 2018 - 2030 (USD Million)
• Fig. 27 Oligo Synthesis market, 2018 - 2030 (USD Million)
• Fig. 28 25 nmol market, 2018 - 2030 (USD Million)
• Fig. 29 50 nmol market, 2018 - 2030 (USD Million)
• Fig. 30 200 nmol market, 2018 - 2030 (USD Million)
• Fig. 31 1000 nmol market, 2018 - 2030 (USD Million)
• Fig. 32 10,000 nmol market, 2018 - 2030 (USD Million)
• Fig. 33 Purification market, 2018 - 2030 (USD Million)
• Fig. 34 Modification market, 2018 - 2030 (USD Million)
• Fig. 35 Oligonucleotide synthesis market: Application segment dashboard
• Fig. 36 Oligonucleotide synthesis market: Application market share analysis, 2024 & 2030
• Fig. 37 Oligonucleotide synthesis market, in PCR Primers, 2018 - 2030 (USD Million)
• Fig. 38 Oligonucleotide synthesis market, in PCR Assays and Panels, 2018 - 2030 (USD Million)
• Fig. 39 Oligonucleotide synthesis market, in Sequencing, 2018 - 2030 (USD Million)
• Fig. 40 Oligonucleotide synthesis market, in DNA Microarrays, 2018 - 2030 (USD Million)
• Fig. 41 Oligonucleotide synthesis market, in Fluorescence In Situ Hybridization (FISH), 2018 - 2030 (USD Million)
• Fig. 42 Oligonucleotide synthesis market, in Antisense Oligonucleotide, 2018 - 2030 (USD Million)
• Fig. 43 Oligonucleotide synthesis market, in Other Applications, 2018 - 2030 (USD Million)
• Fig. 44 Oligonucleotide synthesis market: End use segment dashboard
• Fig. 45 Oligonucleotide synthesis market: End use market share analysis, 2024 & 2030
• Fig. 46 Oligonucleotide synthesis market, in Academic Research Institutes, 2018 - 2030 (USD Million)
• Fig. 47 Oligonucleotide synthesis market, in Diagnostic Laboratories, 2018 - 2030 (USD Million)
• Fig. 48 Oligonucleotide synthesis market, in Pharmaceutical and Biotechnology Companies, 2018 - 2030 (USD Million)
• Fig. 49 Oligonucleotide synthesis market revenue, by region
• Fig. 50 Regional marketplace: Key takeaways
• Fig. 51 Regional marketplace: Key takeaways
• Fig. 52 North America oligonucleotide synthesis market, 2018 - 2030 (USD Million)
• Fig. 53 U.S. country dynamics
• Fig. 54 U.S. oligonucleotide synthesis market, 2018 - 2030 (USD Million)
• Fig. 55 Canada country dynamics
• Fig. 56 Canada oligonucleotide synthesis market, 2018 - 2030 (USD Million)
• Fig. 57 Mexico country dynamics
• Fig. 58 Mexico oligonucleotide synthesis market, 2018 - 2030 (USD Million)
• Fig. 59 Europe oligonucleotide synthesis market, 2018 - 2030 (USD Million)
• Fig. 60 Germany country dynamics
• Fig. 61 Germany oligonucleotide synthesis market, 2018 - 2030 (USD Million)
• Fig. 62 UK country dynamics
• Fig. 63 UK oligonucleotide synthesis market, 2018 - 2030 (USD Million)
• Fig. 64 France country dynamics
• Fig. 65 France oligonucleotide synthesis market, 2018 - 2030 (USD Million)
• Fig. 66 Italy country dynamics
• Fig. 67 Italy oligonucleotide synthesis market, 2018 - 2030 (USD Million)
• Fig. 68 Spain country dynamics
• Fig. 69 Spain oligonucleotide synthesis market, 2018 - 2030 (USD Million)
• Fig. 70 Denmark country dynamics
• Fig. 71 Denmark oligonucleotide synthesis market, 2018 - 2030 (USD Million)
• Fig. 72 Sweden country dynamics
• Fig. 73 Sweden oligonucleotide synthesis market, 2018 - 2030 (USD Million)
• Fig. 74 Norway country dynamics
• Fig. 75 Norway oligonucleotide synthesis market, 2018 - 2030 (USD Million)
• Fig. 76 Asia Pacific oligonucleotide synthesis market, 2018 - 2030 (USD Million)
• Fig. 77 China country dynamics
• Fig. 78 China oligonucleotide synthesis market, 2018 - 2030 (USD Million)
• Fig. 79 India country dynamics
• Fig. 80 India oligonucleotide synthesis market, 2018 - 2030 (USD Million)
• Fig. 81 Japan country dynamics
• Fig. 82 Japan oligonucleotide synthesis market, 2018 - 2030 (USD Million)
• Fig. 83 Australia country dynamics
• Fig. 84 Australia oligonucleotide synthesis market, 2018 - 2030 (USD Million)
• Fig. 85 South Korea country dynamics
• Fig. 86 South Korea oligonucleotide synthesis market, 2018 - 2030 (USD Million)
• Fig. 87 Thailand country dynamics
• Fig. 88 Thailand oligonucleotide synthesis market, 2018 - 2030 (USD Million)
• Fig. 89 Latin America oligonucleotide synthesis market, 2018 - 2030 (USD Million)
• Fig. 90 Brazil country dynamics
• Fig. 91 Brazil oligonucleotide synthesis market, 2018 - 2030 (USD Million)
• Fig. 92 Argentina country dynamics
• Fig. 93 Argentina oligonucleotide synthesis market, 2018 - 2030 (USD Million)
• Fig. 94 Middle East & Africa oligonucleotide synthesis market, 2018 - 2030 (USD Million)
• Fig. 95 South Africa country dynamics
• Fig. 96 South Africa oligonucleotide synthesis market, 2018 - 2030 (USD Million)
• Fig. 97 Saudi Arabia country dynamics
• Fig. 98 Saudi Arabia oligonucleotide synthesis market, 2018 - 2030 (USD Million)
• Fig. 99 UAE country dynamics
• Fig. 100 UAE oligonucleotide synthesis market, 2018 - 2030 (USD Million)
• Fig. 101 Kuwait country dynamics
• Fig. 102 Kuwait oligonucleotide synthesis market, 2018 - 2030 (USD Million)
• Fig. 103 Company categorization
• Fig. 104 Company market position analysis
• Fig. 105 Strategic framework

Oligonucleotide Synthesis Market Growth & Trends:

The global oligonucleotide synthesis market size is expected to reach USD 8.83 billion by 2030, registering a CAGR of 13.2% from 2025 to 2030, according to a new report by Grand View Research, Inc. The strong pipeline of oligonucleotide therapeutics in clinical trials, advancements in gene editing technologies, and increasing R&D spending by biotechnology companies are some of the major factors driving the market growth.

Oligonucleotide therapeutics participants are present in the late stages of clinical trials and are expected to be approved & commercialized over the forecast period. Companies have increased investments to develop oligonucleotide-based therapeutics. In October 2023, GSK plc and Arrowhead Pharmaceuticals announced a contract with Janssen Pharmaceuticals, Inc. (Janssen), a Johnson & Johnson company, to assign GSK exclusive worldwide rights to develop and commercialize JNJ-3989. Janssen initially in-licensed JNJ-3989 (previously ARO-HBV) from Arrowhead in 2018. Similar initiatives by well-established pharmaceutical companies are anticipated to drive market growth over the forecast period.

Government bodies, such as the Centers for Medicaid & Medicare Services for labs, the Federal Trade Commission for marketing, and the FDA for kits & information, have played a key role in the success of genomics, as they have been involved in monitoring the safe, appropriate, and accurate application of genomics & genetic tests. International funding bodies, such as NIH and Wellcome Trust, are engaged in providing funds for genetic studies, which is expected to fuel genomic studies in developed and emerging economies.

In May 2021, the UK government announced a funding of USD 43.4 million (GBP 37 million) for genomics research and data-driven initiatives, delivered via the UK Functional Genomics Initiative and Genome UK Implementation Plan, which was started in September 2019. The Genome UK strategy will be implemented with the help of the Genomics England project, which will receive USD 19.9 million (GBP 17 million) to investigate the potential value of newborn sequencing.

Oligonucleotide Synthesis Market Report Highlights:

• The services segment dominated the oligonucleotide synthesis market, accounting for the largest revenue share of 31.5% in 2024. The oligonucleotides segment is expected to grow at a significant CAGR of 13.0% over the forecast period.
• PCR primers led the oligonucleotide synthesis industry with the largest revenue share in 2024. The sequencing segment is expected to grow at the fastest CAGR over the forecast period.
• The academic research institutes dominated the oligonucleotide synthesis market with the largest revenue share in 2024. The pharmaceutical and biotechnology companies segment is expected to grow significantly over the forecast period.
• The North America oligonucleotide synthesis market dominated the oligonucleotide synthesis industry with the largest revenue share of 31.9% in 2024. The Asia Pacific oligonucleotide synthesis market is expected to grow at the fastest CAGR of 14.9% over the forecast period.

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation & Scope
• 1.2. Segment Definitions
  • 1.2.1. Product
  • 1.2.2. Application
  • 1.2.3. End Use
• 1.3. Estimates and Forecast Timeline
• 1.4. Research Methodology
• 1.5. Information Procurement
  • 1.5.1. Purchased Database
  • 1.5.2. GVR's Internal Database
  • 1.5.3. Secondary Sources
  • 1.5.4. Primary Research
• 1.6. Information Analysis
  • 1.6.1. Data Analysis Models
• 1.7. Market Formulation & Data Visualization
• 1.8. Model Details
  • 1.8.1. Commodity Flow Analysis
• 1.9. List of Secondary Sources
• 1.10. Objectives

Chapter 2. Executive Summary

• 2.1. Market Snapshot
• 2.2. Segment Snapshot
• 2.3. Competitive Landscape Snapshot

Chapter 3. Oligonucleotide Synthesis Market Variables, Trends, & Scope

• 3.1. Market Lineage Outlook
• 3.2. Market Dynamics
  • 3.2.1. Market Driver Analysis
  • 3.2.2. Market Restraint Analysis
• 3.3. Business Environment Analysis
  • 3.3.1. Industry Analysis - Porter's Five Forces Analysis
    • 3.3.1.1. Supplier Power
    • 3.3.1.2. Buyer Power
    • 3.3.1.3. Substitution Threat
    • 3.3.1.4. Threat of New Entrants
    • 3.3.1.5. Competitive Rivalry
  • 3.3.2. PESTLE Analysis

Chapter 4. Oligonucleotide Synthesis Market: Product Business Analysis

• 4.1. Product Market Share, 2024 & 2030
• 4.2. Product Segment Dashboard
• 4.3. Market Size & Forecasts and Trend Analysis, by Product, 2018 to 2030 (USD Million)
• 4.4. Oligonucleotides
  • 4.4.1. Oligonucleotides Market, 2018 - 2030 (USD Million)
  • 4.4.2. Product Type
    • 4.4.2.1. Product Type Market, 2018 - 2030 (USD Million)
    • 4.4.2.2. Column-based Oligos
      • 4.4.2.2.1. Column-based Oligos Market, 2018 - 2030 (USD Million)
    • 4.4.2.3. Array-based Oligos
      • 4.4.2.3.1. Array-based Oligos Market, 2018 - 2030 (USD Million)
  • 4.4.3. Nucleic Acid Type
    • 4.4.3.1. Nucleic Acid Type Market, 2018 - 2030 (USD Million)
    • 4.4.3.2. DNA
      • 4.4.3.2.1. DNA Market, 2018 - 2030 (USD Million)
    • 4.4.3.3. RNA
      • 4.4.3.3.1. RNA Market, 2018 - 2030 (USD Million)
• 4.5. Equipment/Synthesizer
  • 4.5.1. Equipment/Synthesizer Market, 2018 - 2030 (USD Million)
• 4.6. Reagents
  • 4.6.1. Reagents Market, 2018 - 2030 (USD Million)
• 4.7. Services
  • 4.7.1. Services Market, 2018 - 2030 (USD Million)
  • 4.7.2. Oligo Synthesis
    • 4.7.2.1. Oligo Synthesis Market, 2018 - 2030 (USD Million)
    • 4.7.2.2. 25 nmol
      • 4.7.2.2.1. 25 nmol Market, 2018 - 2030 (USD Million)
    • 4.7.2.3. 50 nmol
      • 4.7.2.3.1. 50 nmol Market, 2018 - 2030 (USD Million)
    • 4.7.2.4. 200 nmol
      • 4.7.2.4.1. 200 nmol Market, 2018 - 2030 (USD Million)
    • 4.7.2.5. 1000nmol
      • 4.7.2.5.1. 1000nmol Market, 2018 - 2030 (USD Million)
    • 4.7.2.6. 10,000 nmol
      • 4.7.2.6.1. 10,000 nmol Market, 2018 - 2030 (USD Million)
  • 4.7.3. Purification
    • 4.7.3.1. Purification Market, 2018 - 2030 (USD Million)
  • 4.7.4. Modification
    • 4.7.4.1. Modification Market, 2018 - 2030 (USD Million)

Chapter 5. Oligonucleotide Synthesis Market: Application Business Analysis

• 5.1. Application Market Share, 2024 & 2030
• 5.2. Application Segment Dashboard
• 5.3. Market Size & Forecasts and Trend Analysis, by Application, 2018 to 2030 (USD Million)
• 5.4. PCR Primers
  • 5.4.1. Oligonucleotide Synthesis Market, in PCR Primers, 2018 - 2030 (USD Million)
• 5.5. PCR Assays and Panels
  • 5.5.1. Oligonucleotide Synthesis Market, in PCR Assays and Panels, 2018 - 2030 (USD Million)
• 5.6. Sequencing
  • 5.6.1. Oligonucleotide Synthesis Market, in Sequencing, 2018 - 2030 (USD Million)
• 5.7. DNA Microarrays
  • 5.7.1. Oligonucleotide Synthesis Market, in DNA Microarrays, 2018 - 2030 (USD Million)
• 5.8. Fluorescence In Situ Hybridization (FISH)
  • 5.8.1. Oligonucleotide Synthesis Market, in Fluorescence In Situ Hybridization (FISH), 2018 - 2030 (USD Million)
• 5.9. Antisense Oligonucleotides
  • 5.9.1. Oligonucleotide Synthesis Market, in Antisense Oligonucleotides, 2018 - 2030 (USD Million)
• 5.10. Other Applications
  • 5.10.1. Oligonucleotide Synthesis Market, in Other Applications, 2018 - 2030 (USD Million)

Chapter 6. Oligonucleotide Synthesis Market: End Use Business Analysis

• 6.1. End Use Market Share, 2024 & 2030
• 6.2. End Use Segment Dashboard
• 6.3. Market Size & Forecasts and Trend Analysis, by End Use, 2018 to 2030 (USD Million)
• 6.4. Academic Research Institutes
  • 6.4.1. Oligonucleotide Synthesis Market, in Academic Research Institutes, 2018 - 2030 (USD Million)
• 6.5. Diagnostic Laboratories
  • 6.5.1. Oligonucleotide Synthesis Market, in Diagnostic Laboratories, 2018 - 2030 (USD Million)
• 6.6. Pharmaceutical and Biotechnology Companies
  • 6.6.1. Oligonucleotide Synthesis Market, in Pharmaceutical and Biotechnology Companies, 2018 - 2030 (USD Million)

Chapter 7. Oligonucleotide Synthesis Market: Regional Estimates & Trend Analysis

• 7.1. Regional Market Share Analysis, 2024 & 2030
• 7.2. Regional Market Dashboard
• 7.3. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
• 7.4. North America
  • 7.4.1. North America Oligonucleotide Synthesis Market Estimates And Forecasts, By Country, 2018 - 2030 (USD Million)
  • 7.4.2. U.S.
    • 7.4.2.1. Key Country Dynamics
    • 7.4.2.2. Regulatory Framework
    • 7.4.2.3. Competitive Insights
    • 7.4.2.4. U.S. Oligonucleotide Synthesis Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 7.4.3. Canada
    • 7.4.3.1. Key Country Dynamics
    • 7.4.3.2. Regulatory Framework
    • 7.4.3.3. Competitive Insights
    • 7.4.3.4. Canada Oligonucleotide Synthesis Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 7.4.4. Mexico
    • 7.4.4.1. Key Country Dynamics
    • 7.4.4.2. Regulatory Framework
    • 7.4.4.3. Competitive Insights
    • 7.4.4.4. Mexico Oligonucleotide Synthesis Market Estimates And Forecasts, 2018 - 2030 (USD Million)
• 7.5. Europe
  • 7.5.1. Europe Oligonucleotide Synthesis Market Estimates And Forecasts, By Country, 2018 - 2030 (USD Million)
  • 7.5.2. Germany
    • 7.5.2.1. Key Country Dynamics
    • 7.5.2.2. Regulatory Framework
    • 7.5.2.3. Competitive Insights
    • 7.5.2.4. Germany Oligonucleotide Synthesis Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 7.5.3. UK
    • 7.5.3.1. Key Country Dynamics
    • 7.5.3.2. Regulatory Framework
    • 7.5.3.3. Competitive Insights
    • 7.5.3.4. UK Oligonucleotide Synthesis Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 7.5.4. France
    • 7.5.4.1. Key Country Dynamics
    • 7.5.4.2. Regulatory Framework
    • 7.5.4.3. Competitive Insights
    • 7.5.4.4. France Oligonucleotide Synthesis Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 7.5.5. Italy
    • 7.5.5.1. Key Country Dynamics
    • 7.5.5.2. Regulatory Framework
    • 7.5.5.3. Competitive Insights
    • 7.5.5.4. Italy Oligonucleotide Synthesis Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 7.5.6. Spain
    • 7.5.6.1. Key Country Dynamics
    • 7.5.6.2. Regulatory Framework
    • 7.5.6.3. Competitive Insights
    • 7.5.6.4. Spain Oligonucleotide Synthesis Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 7.5.7. Denmark
    • 7.5.7.1. Key Country Dynamics
    • 7.5.7.2. Regulatory Framework
    • 7.5.7.3. Competitive Insights
    • 7.5.7.4. Denmark Oligonucleotide Synthesis Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 7.5.8. Sweden
    • 7.5.8.1. Key Country Dynamics
    • 7.5.8.2. Regulatory Framework
    • 7.5.8.3. Competitive Insights
    • 7.5.8.4. Sweden Oligonucleotide Synthesis Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 7.5.9. Norway
    • 7.5.9.1. Key Country Dynamics
    • 7.5.9.2. Regulatory Framework
    • 7.5.9.3. Competitive Insights
    • 7.5.9.4. Norway Oligonucleotide Synthesis Market Estimates And Forecasts, 2018 - 2030 (USD Million)
• 7.6. Asia Pacific
  • 7.6.1. Asia Pacific Oligonucleotide Synthesis Market Estimates And Forecasts, By Country, 2018 - 2030 (USD Million)
  • 7.6.2. China
    • 7.6.2.1. Key Country Dynamics
    • 7.6.2.2. Regulatory Framework
    • 7.6.2.3. Competitive Insights
    • 7.6.2.4. China Oligonucleotide Synthesis Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 7.6.3. India
    • 7.6.3.1. Key Country Dynamics
    • 7.6.3.2. Regulatory Framework
    • 7.6.3.3. Competitive Insights
    • 7.6.3.4. India Oligonucleotide Synthesis Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 7.6.4. Japan
    • 7.6.4.1. Key Country Dynamics
    • 7.6.4.2. Regulatory Framework
    • 7.6.4.3. Competitive Insights
    • 7.6.4.4. Japan Oligonucleotide Synthesis Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 7.6.5. Australia
    • 7.6.5.1. Key Country Dynamics
    • 7.6.5.2. Regulatory Framework
    • 7.6.5.3. Competitive Insights
    • 7.6.5.4. Australia Oligonucleotide Synthesis Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 7.6.6. South Korea
    • 7.6.6.1. Key Country Dynamics
    • 7.6.6.2. Regulatory Framework
    • 7.6.6.3. Competitive Insights
    • 7.6.6.4. South Korea Oligonucleotide Synthesis Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 7.6.7. Thailand
    • 7.6.7.1. Key Country Dynamics
    • 7.6.7.2. Regulatory Framework
    • 7.6.7.3. Competitive Insights
    • 7.6.7.4. Thailand Oligonucleotide Synthesis Market Estimates And Forecasts, 2018 - 2030 (USD Million)
• 7.7. Latin America
  • 7.7.1. Latin America Oligonucleotide Synthesis Market Estimates And Forecasts, By Country, 2018 - 2030 (USD Million)
  • 7.7.2. Brazil
    • 7.7.2.1. Key Country Dynamics
    • 7.7.2.2. Regulatory Framework
    • 7.7.2.3. Competitive Insights
    • 7.7.2.4. Brazil Oligonucleotide Synthesis Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 7.7.3. Argentina
    • 7.7.3.1. Key Country Dynamics
    • 7.7.3.2. Regulatory Framework
    • 7.7.3.3. Competitive Insights
    • 7.7.3.4. Argentina Oligonucleotide Synthesis Market Estimates And Forecasts, 2018 - 2030 (USD Million)
• 7.8. Middle East & Africa
  • 7.8.1. Middle East & Africa Oligonucleotide Synthesis Market Estimates And Forecasts, By Country, 2018 - 2030 (USD Million)
  • 7.8.2. South Africa
    • 7.8.2.1. Key Country Dynamics
    • 7.8.2.2. Regulatory Framework
    • 7.8.2.3. Competitive Insights
    • 7.8.2.4. South Africa Oligonucleotide Synthesis Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 7.8.3. Saudi Arabia
    • 7.8.3.1. Key Country Dynamics
    • 7.8.3.2. Regulatory Framework
    • 7.8.3.3. Competitive Insights
    • 7.8.3.4. Saudi Arabia Oligonucleotide Synthesis Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 7.8.4. UAE
    • 7.8.4.1. Key Country Dynamics
    • 7.8.4.2. Regulatory Framework
    • 7.8.4.3. Competitive Insights
    • 7.8.4.4. UAE Oligonucleotide Synthesis Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 7.8.5. Kuwait
    • 7.8.5.1. Key Country Dynamics
    • 7.8.5.2. Regulatory Framework
    • 7.8.5.3. Competitive Insights
    • 7.8.5.4. Kuwait Oligonucleotide Synthesis Market Estimates And Forecasts, 2018 - 2030 (USD Million)

Chapter 8. Competitive Landscape

• 8.1. Participant Overview
• 8.2. Company Market Position Analysis
• 8.3. Company Categorization
• 8.4. Strategy Mapping
• 8.5. Company Profiles/Listing
  • 8.5.1. Thermo Fisher Scientific Inc.
    • 8.5.1.1. Overview
    • 8.5.1.2. Financial Performance
    • 8.5.1.3. Type Benchmarking
    • 8.5.1.4. Strategic Initiatives
  • 8.5.2. Merck KGaA
    • 8.5.2.1. Overview
    • 8.5.2.2. Financial Performance
    • 8.5.2.3. Type Benchmarking
    • 8.5.2.4. Strategic Initiatives
  • 8.5.3. Danaher
    • 8.5.3.1. Overview
    • 8.5.3.2. Financial Performance
    • 8.5.3.3. Type Benchmarking
    • 8.5.3.4. Strategic Initiatives
  • 8.5.4. Revvity Discovery Limited
    • 8.5.4.1. Overview
    • 8.5.4.2. Financial Performance
    • 8.5.4.3. Type Benchmarking
    • 8.5.4.4. Strategic Initiatives
  • 8.5.5. Agilent Technologies, Inc.
    • 8.5.5.1. Overview
    • 8.5.5.2. Financial Performance
    • 8.5.5.3. Type Benchmarking
    • 8.5.5.4. Strategic Initiatives
  • 8.5.6. Bio-Synthesis, Inc.
    • 8.5.6.1. Overview
    • 8.5.6.2. Financial Performance
    • 8.5.6.3. Type Benchmarking
    • 8.5.6.4. Strategic Initiatives
  • 8.5.7. Kaneka Eurogentec S.A.
    • 8.5.7.1. Overview
    • 8.5.7.2. Financial Performance
    • 8.5.7.3. Type Benchmarking
    • 8.5.7.4. Strategic Initiatives
  • 8.5.8. LGC Biosearch Technologies
    • 8.5.8.1. Overview
    • 8.5.8.2. Financial Performance
    • 8.5.8.3. Type Benchmarking
    • 8.5.8.4. Strategic Initiatives
  • 8.5.9. Biolegio
    • 8.5.9.1. Overview
    • 8.5.9.2. Financial Performance
    • 8.5.9.3. Type Benchmarking
    • 8.5.9.4. Strategic Initiatives
  • 8.5.10. Twist Bioscience
    • 8.5.10.1. Overview
    • 8.5.10.2. Financial Performance
    • 8.5.10.3. Type Benchmarking
    • 8.5.10.4. Strategic Initiatives